Adamas provides program update for ADS-5102 for multiple sclerosis patients with walking impairment
EMERYVILLE, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering […]